Statistics

Total Visits

Views
Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib38

Select a period of time:

Number of views in the range

Views
Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib19

Views

Views
December 20240
January 20250
February 20255
March 202511
April 20252
May 20250
June 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States2
Brazil1
Spain1
United Kingdom1
 

Top cities views

Views
Council Bluffs1
Poá1